Latest News
TSMC Projects $1.5T Semiconductor Market by 2030 as AI Demand Surges
TSMC now expects the global semiconductor market to exceed $1.5 trillion by 2030, fueled by AI. The company also outlined aggressive capacity expansion and advanced packaging milestones.
Dow Inches Higher, Nasdaq Slips as Bond Yield Retreat Fails to Calm Markets
Stocks were mixed Monday as the Dow edged up but the Nasdaq fell, with bond yields pulling back from recent highs. Dominion Energy jumped on a $66.8B acquisition by NextEra, while Regeneron slid on a trial miss.
Intel Edges Higher as AI-Driven Demand Offsets Market Jitters
Intel shares inched up Monday as analysts raised targets and the AI narrative gained traction. Data center revenue surged 22%, but server CPU market share slipped.
BofA Turns Bearish on Salesforce, Flags AI Risk to Growth Model
BofA Securities reinstated Salesforce with an Underperform rating and $160 target, citing AI risks to its growth model. Shares rose despite the bearish note.
Sanctions Waiver Hints Send Oil Lower, Bonds Steady Amid Strait of Hormuz Crisis
Oil prices fell Monday after reports the U.S. may offer Iran a temporary sanctions waiver, easing earlier panic over the closed Strait of Hormuz. Brent crude dropped below $108, while the 10-year Treasury yield hit 4.631%.
Alphabet Stock Gains Ahead of Google I/O; BofA Reaffirms Buy Rating
Alphabet shares rose over 1% Monday, nearing $4.9 trillion market cap, as Bank of America reiterated Buy with $430 target ahead of Google I/O. Analysts highlight AI and cloud momentum but caution on elevated expectations.
Quince Therapeutics Faces Nasdaq Listing Uncertainty Amid Going Concern Warning
Quince Therapeutics stock trades near $1.15 as the company faces Nasdaq compliance issues, a going concern warning, and a failed Phase 3 trial, with a shareholder vote on a reverse stock split scheduled for June 11.
Berkshire Hathaway Takes Stake in Macy's; Stock Rises in Pre-Market
Berkshire Hathaway's new 3.04 million share stake in Macy's, valued at $55 million, lifted shares in pre-market. Q1 results are due June 3, with headwinds from tariffs and weak spending.
ImmunityBio Secures Patents and BCG Supply Deal for Bladder Cancer Therapy
ImmunityBio announced five U.S. patents protecting its Anktiva-plus-BCG bladder cancer therapy through 2035, and an exclusive supply deal for the Tokyo-172 BCG strain.
Virax Biolabs Surges on TV Segment and Ownership Filing
Virax Biolabs shares surged over 125% in pre-market trading Monday after a sponsored TV segment featuring its CEO and a new SEC filing revealed Armistice Capital holds a 4.99% stake.